| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 54, 450-454, Copyright © 1982 by Endocrine Society
ARTICLES |
SW Lamberts, JM Timmers, R Oosterom, T Verleun and FH de Jong
A patient with virilization was studied. The basal urinary excretion of 17-ketosteroids was at the upper limit of normal, but the plasma testosterone concentration was greatly elevated. Testosterone secretion could be stimulated by hCG, suppressed by dexamethasone, and was not affected by ACTH. At operation, an arrhenoblastoma of the left ovary was found. Isolated tumor cells in culture secreted testosterone. The addition of a LRH agonist (10 ng/ml) suppressed the secretion of testosterone by 50% (P less than 0.01). The inhibiting effect of a LRH agonist on steroidogenesis suggests that LRH receptors were present on this tumor and that treatment with LRH agonists might be beneficial in patients with metastatic steroid hormone-secreting ovarian and testicular tumors.
This article has been cited by other articles:
![]() |
J.W. Stephens, J.R. Katz, N. McDermott, A.B. MacLean, and P-M.G. Bouloux An unusual steroid-producing ovarian tumour: Case report Hum. Reprod., June 1, 2002; 17(6): 1468 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Barnes and D. A. Ehrmann Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1746 - 1748. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |